Journavx (suzetrigine) - Vertex
Suzetrigine Post DIEP (clinicaltrials.gov) - Sep 25, 2026 - P3 | N=198 | Not yet recruiting | Sponsor: Vanderbilt University Medical Center 
New P3 trial • Pain
http://clinicaltrials.gov/ct2/show/NCT07839715
 
Sep 25, 2026
 
Prev Next